Results 91 to 100 of about 929,362 (315)
Disability prediction in multiple sclerosis using performance outcome measures and demographic data [PDF]
arXiv, 2022 Literature on machine learning for multiple sclerosis has primarily focused on the use of neuroimaging data such as magnetic resonance imaging and clinical laboratory tests for disease identification. However, studies have shown that these modalities are not consistent with disease activity such as symptoms or disease progression. Furthermore, the cost
arxiv
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis. [PDF]
, 2012 Multiple sclerosis (MS) is a demyelinating immune-mediated disease of the central nervous system (CNS). It is the most frequent neurological disease in young adults and affects over 2 million people worldwide.
Aigner, Ludwig, Rivera, Francisco J
core +2 more sources
Plasma exchange in progressive systemic sclerosis
American Journal of Experimental and Clinical Research, 2015 Systemic sclerosis (SSc) is an autoimmune systemic disease of unknown etiology. Present treatment modalities have limited impact on clinical/ laboratory outcomes.
Mohammad Bagher Owlia
doaj
Gender and uveitis in patients with multiple sclerosis. [PDF]
, 2014 Multiple sclerosis (MS), a demyelinating disease of the central nervous system, is more commonly seen in women. It has been associated with both anterior and intermediate uveitis as well as retinal vasculitis.
Goldstein, Debra A, Gordon, Lynn K
core +3 more sources
Bronchioloalveolar Carcinoma in Progressive Systemic Sclerosis
The Korean Journal of Internal Medicine, 1987 Bronchioloalveolar carcinoma(BAC) is the most common histological type of lung cancer arising in an area of scar tissue, and it is frequently superimposed in the fibrotic lung of progressive systemic sclerosis(PSS). The so called scar cancer is believed to be caused by the transformation of hyperplastic epithelium to metaplasia and finally to neoplasia
Do Yung Shin +4 more
openaire +3 more sources
Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement
Egyptian Journal of Chest Disease and Tuberculosis, 2015 Background: A progressive pulmonary involvement is frequent in systemic sclerosis and it is the leading cause of morbidity and mortality. IL-6 has been implicated in the pathogenesis of systemic sclerosis via stimulation of fibroblasts to produce excess ...
Maha Yousif +4 more
doaj +1 more source
Fresh Insights into Disease Etiology and the Role of Microbial Pathogens. [PDF]
, 2016 Pathogens have been implicated in the initiation and/or promotion of systemic sclerosis (scleroderma, SSc); however, no evidence was found to substantiate the direct contribution to this disease in past years.
FARINA, Antonella, Farina, G.a.2.
core +1 more source
Journal of Cellular and Molecular Medicine, 2013 Telocytes, a peculiar type of stromal cells, have been recently identified in a variety of tissues and organs, including human skin. Systemic sclerosis (SSc, scleroderma) is a complex connective tissue disease characterized by fibrosis of the skin and ...
M. Manetti +6 more
semanticscholar +1 more source
Concurrent Validity of Automatic Speech and Pause Measures During Passage Reading in ALS [PDF]
arXiv, 2022 The analysis of speech measures in individuals with amyotrophic lateral sclerosis (ALS) can provide essential information for early diagnosis and tracking disease progression. However, current methods for extracting speech and pause features are manual or semi-automatic, which makes them time-consuming and labour-intensive.
arxiv
The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases. [PDF]
, 2015 The systemic and organ-specific human fibrotic disorders collectively represent one of the most serious health problems world-wide causing a large proportion of the total world population mortality.
Ballater R +32 more
core +2 more sources